Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
65.68
+4.87 (8.01%)
At close: Nov 4, 2026, 4:00 PM EST
65.99
+0.31 (0.47%)
Pre-market: Nov 5, 2026, 7:27 AM EST
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year. That makes Vaxcyte the 19,920th largest employer in the world and 2,673rd in the United States.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$2,265,272
Market Cap
10.34B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,000 |
| Caris Life Sciences | 1,846 |
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Krystal Biotech | 295 |
PCVX News
- 15 hours ago - Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 16 hours ago - Vaxcyte Earnings release: Q3 2026 - Filings
- 16 hours ago - Vaxcyte Quarterly report: Q3 2026 - Filings
- 4 weeks ago - Vaxcyte 7.412M share Spot Secondary priced at $64.00 - TheFly
- 4 weeks ago - Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes - GlobeNewsWire
- 4 weeks ago - Vaxcyte falls -11.3% - TheFly
- 4 weeks ago - Vaxcyte price target raised to $146 from $130 at BofA - TheFly
- 4 weeks ago - Vaxcyte files to sell $500M of common stock, $500M of convertible senior notes - TheFly